Dr. Bosl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
New York, NY 10065Phone+1 212-639-2000
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 1977 - 1979
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1973 - 1975
Creighton University School of MedicineClass of 1973
Certifications & Licensure
NY State Medical License 1974 - 2026
MN State Medical License 1977 - 1979- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Publications & Presentations
PubMed
- 443 citationsComputerized Quantitation of Synergism and Antagonism of Taxol, Topotecan, and Cisplatin Against Human Teratocarcinoma Cell Growth: a Rational Approach to Clinical Pro...Ting-Chao Chou, Robert J. Motzer, Youzhi Tong, George J. Bosl
Journal of the National Cancer Institute. 1994-10-19 - 56 citationsProgression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: endpoints for clinical trial design.Darren R. Feldman, Sujata Patil, M. J. Trinos, Maryann Carousso, Michelle S. Ginsberg
Cancer. 2012-02-15 - 116 citationsCT Findings of Chemotherapy-induced Toxicity: What Radiologists Need to Know about the Clinical and Radiologic Manifestations of Chemotherapy ToxicityJean Torrisi, Lawrence H. Schwartz, Marc J. Gollub, Michelle S. Ginsberg, George J. Bosl
Radiology. 2011-01-01
Press Mentions
Examining the Role of Docetaxel with Radiation Therapy and ADT in Non-Metastatic Prostate Cancer - Anthony D'Amico & Philip KantoffJune 7th, 2021
How Often to Follow up? Study Shows Two CT Scans as Good as Five for Low-Risk Testicular CancerJune 25th, 2007
Grant Support
- Development Of An Aging And Cancer Program At MskccNational Cancer Institute2003–2007
- Cancer Chemotherapy Training ProgramNational Cancer Institute1996–2005
- Cancer Chemotherapy Program ProjectNational Cancer Institute2001–2004
- Mechanism Of Action Of Folate AntagonistsNational Cancer Institute2002
- Solid TumorNational Cancer Institute2001–2002
- Memorial Hospital And Cancer And Acute Leukemia Group BNational Cancer Institute1998–2001
- Clinical Correlative Studies In Germ Cell TumorsNational Cancer Institute1998–2000
- Chemotherapeutic Studies In Solid TumorsNational Cancer Institute1997–2000
- Clinical Correlative Studies In Germ Cell TumorsNational Cancer Institute1993–1996
- Statistical Methods In Cancer Clinical TrialsNational Cancer Institute1990
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
